The FDA just cleared two senolytic drugs, and the ripple effects could rewrite the roadmap for extending healthy life. Discover why investors, scientists, and biohackers are all watching this turning point.
Orson
Posted on Originally published at longevitynotes.online
7 Years of Senolytic Approvals Push Longevity Science Far
For further actions, you may consider blocking this person and/or reporting abuse
Top comments (0)